DOUBLE ALKYLATING AGENTS TREATMENT WITH IFOSFAMIDE (IFOS) AND CYCLOPHOSPHAMIDE (CYCLO) FOR RELAPSED PEDIATRIC SOLID TUMORS

被引：0
|
作者：
Epelman, Sidnei [1 ]
Gorender, Ethel [1 ]
Beaugrand, Annick [1 ]
Meirelles, Priscilla [1 ]
Oliveira, Renato [1 ]
Melaragno, Renato [1 ]
机构：
[1] Santa Marcelina Hosp, Sao Paulo, Brazil
来源：
PEDIATRIC BLOOD & CANCER | 2012年 / 59卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1093 / 1093
页数：1
相关论文
共 50 条
  • [21] Irinotecan plus temozolomide in refractory or relapsed pediatric solid tumors
    Hernandez-Marques, C.
    Lassaletta-Atienza, A.
    Ruiz Hernandez, A.
    Blumenfeld Olivares, J. A.
    Arce Abaitua, B.
    Cormenzana Carpio, M.
    Madero Lopez, L.
    ANALES DE PEDIATRIA, 2013, 79 (02): : 68 - 74
  • [22] Vincristine, irinotecan, and temozolomide treatment for refractory/relapsed pediatric solid tumors: A single center experience
    Bay, Sema Bueyukkapu
    Kebudi, Rejin
    Gorgun, Omer
    Zulfikar, Buelent
    Darendeliler, Emin
    Cakir, Fatma B.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019, 25 (06) : 1343 - 1348
  • [23] CURRENT STUDIES OF IFOSFAMIDE FOR PEDIATRIC SOLID TUMORS AND LEUKEMIA IN THE UNITED-STATES
    PRATT, CB
    SEMINARS IN ONCOLOGY, 1992, 19 (06) : 43 - 50
  • [24] PRINCIPLES OF TREATMENT OF PEDIATRIC SOLID TUMORS
    BERG, SL
    GRISELL, DL
    DELANEY, TF
    BALIS, FM
    PEDIATRIC CLINICS OF NORTH AMERICA, 1991, 38 (02) : 249 - 267
  • [25] Fractionated high-dose cyclophosphamide for advanced pediatric solid tumors
    Chan, LL
    Ater, J
    Cangir, A
    Jaffe, N
    Raney, RB
    Herzog, C
    Culbert, S
    Chan, KW
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1996, 18 (01) : 63 - 67
  • [26] POPULATION PHARMACOKINETICS OF TEMSIROLIMUS IN PEDIATRIC PATIENTS WITH RELAPSED/REFRACTORY SOLID TUMORS
    Liao, S.
    Spunt, S. L.
    Shapiro, M.
    Boni, J.
    ANNALS OF ONCOLOGY, 2010, 21 : 179 - 180
  • [27] GEMCITABINE AND NAB-PACLITAXEL FOR PEDIATRIC RELAPSED AND REFRACTORY SOLID TUMORS
    Metts, Jonathan
    Clark, Dana
    Alazraki, Adina
    Wasilewski-Masker, Karen
    George, Bradley
    Olson, Thomas
    Cash, Thomas
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S8 - S8
  • [28] Population Pharmacokinetic model of trebananib in pediatric patients with relapsed solid tumors
    Abdelrahman, Ramy A.
    Leary, Sarah E. S.
    Reid, Joel M.
    Minard, Charles G.
    Fox, Elizabeth
    Weigel, Brenda
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2016, 43 : S76 - S77
  • [29] Investigating the heterogeneity of alkylating agents' efficacy between genders: A meta-analysis of randomized trials comparing cyclophosphamide and ifosfamide (MAIAGE study).
    Fresneau, Brice
    Paulussen, Michael
    Hackshaw, Alan
    Hawkins, Douglas S.
    Anderson, James R.
    Judson, Ian Robert
    Dirksen, Uta
    Lewis, Ian J.
    Van Den Berg, Hendrik
    Gaspar, Nathalie
    Gelderblom, Hans
    Whelan, Jeremy
    Boos, Joachim
    Wheatley, Keith
    Pignon, Jean-Pierre
    Le Deley, Marie-Cecile
    Le Teuff, Gwenael
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [30] A Phase 1 Trial of Olaratumab as Monotherapy and in Combination with Doxorubicin, Vincristine/Irinotecan, or High-Dose Ifosfamide in Pediatric Patients with Relapsed/Refractory Solid Tumors
    Mascarenhas, L.
    Ogawa, C.
    Laetsch, T.
    Weigel, B.
    Bishop, M.
    Krystal, J.
    Levy, D.
    Mo, G.
    Wright, J.
    Dubois, S.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S433 - S434
12345